Curriculum Vitaes

Saitoh Sei

  (齊藤 成)

Profile Information

Affiliation
Fujita Health University
Degree
医学博士(山梨大学)
医師免許
死体解剖資格認定

J-GLOBAL ID
200901046035768325
researchmap Member ID
6000017924

External link

Papers

 65
  • Koyo Yoshidomi, Kazuo Kunisawa, Masaya Hasegawa, Yuki Kon, Aika Kosuge, Moeka Tanabe, Haruto Ojika, Yasuko Yamamoto, Hidetsugu Fujigaki, Suwako Fujigaki, Hiroyuki Tezuka, Sei Saitoh, Kanako Kumamoto, Masanori Kugita, Shizuko Nagao, Kuniaki Saito, Toshitaka Nabeshima, Akihiro Mouri
    Neurochemistry international, 195 106141-106141, Mar 5, 2026  Peer-reviewed
    Multiple sclerosis (MS) is a common autoimmune demyelinating disease of the central nervous system (CNS). Although activation of the kynurenine (KYN) pathway has been observed in patients with MS, its pathological significance remains unclear. In this study, we investigated the role of the KYN pathway in MS using an experimental autoimmune encephalomyelitis (EAE) mouse model, a widely recognized animal model of MS. We found an increase in the expression of kynureninase (KYNU), a key enzyme in the KYN pathway that is specifically localized within monocytes in the spinal cord of EAE mice. This was accompanied by a significant accumulation of quinolinic acid (QUIN) in the spinal cord. Importantly, similar increases in KYNU expression and QUIN levels were observed in the spinal cord of proteolipid protein overexpressing mice (PLP-tg mice), another model of demyelination. Notably, KYNU knockout (KO) reduced EAE severity and monocyte recruitment to the spinal cord of EAE model mice. These findings suggest that the increase in KYNU expression and the subsequent accumulation of QUIN may contribute to the exacerbation of MS. Taken together, our results indicate that KYNU could be a novel therapeutic target for MS.
  • Kanako Kumamoto, Hiroyuki Kagami, Sei Saitoh, Shiori Yamada, Mami Matsumoto, Nobuhiko Ohno
    Scientific reports, Mar 1, 2026  Peer-reviewed
  • Liqing Zang, Sei Saitoh, Kan Katayama, Weibin Zhou, Norihiro Nishimura, Yasuhito Shimada
    Disease models & mechanisms, 17(5), May 1, 2024  Peer-reviewed
    Diabetic nephropathy (DN), as a complication of diabetes, is a substantial healthcare challenge owing to the high risk of morbidity and mortality involved. Although significant progress has been made in understanding the pathogenesis of DN, more efficient models are required to develop new therapeutics. Here, we created a DN model in zebrafish by crossing diabetic Tg(acta1:dnIGF1R-EGFP) and proteinuria-tracing Tg(l-fabp::VDBP-GFP) lines, named zMIR/VDBP. Overfed adult zMIR/VDBP fish developed severe hyperglycemia and proteinuria, which were not observed in wild-type zebrafish. Renal histopathology revealed human DN-like characteristics, such as glomerular basement membrane thickening, foot process effacement and glomerular sclerosis. Glomerular dysfunction was restored upon calorie restriction. RNA sequencing analysis demonstrated that DN zebrafish kidneys exhibited transcriptional patterns similar to those seen in human DN pathogenesis. Notably, the phosphatidylinositol 3-kinase (PI3K)/protein kinase B (Akt) signaling pathway was activated, a phenomenon observed in the early phase of human DN. In addition, metformin improved hyperglycemia and proteinuria in DN zebrafish by modulating Akt phosphorylation. Our results indicate that zMIR/VDBP fish are suitable for elucidating the mechanisms underlying human DN and could be a powerful tool for therapeutic discovery.
  • Kunisawa K, Hara M, Yoshidomi K, Kon Y, Yamamoto Y, Fujigaki S, Wulaer B, Kosuge A, Tanabe M, Saitoh S, Takahashi K, Saito K, Nabeshima T, Mouri A
    Molecular Neurobiology., May, 2024  Peer-reviewed

Misc.

 39

Books and Other Publications

 10

Teaching Experience

 5

Industrial Property Rights

 1

Social Activities

 2